Aurora Cannabis Inc (TSX: ACB) (NYSE: ACB) has been on a steady rise in recent weeks since uplisting to the NYSE under the symbol “ACB” The stock has seen a boost leading up to mid terms which resulted in Michigan voting to legalize the recreational use of cannabis, while Utah and Missouri legalized it for medical use.
Aurora CEO Terry Booth said at the time “Aurora has rapidly developed into a globally mature organization with industry leading and technologically advanced production facilities available to produce at unprecedented scale to meet the growing demand for high-quality cannabis both in Canada and abroad. We are also uniquely committed to leveraging our deep knowledge base to further scientific research into medical applications of cannabis, and developing novel, higher-margin product offerings that strongly differentiate Aurora from our competition.”
Aurora Cannabis Inc (TSX: ACB) (NYSE: ACB) is a Canadian licensed cannabis producer, headquartered in Edmonton that boasts the words largest funded capacity in excess of 570,000 kg per year and sales and operations in 14 countries across five continents. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution. Aurora’s line of products includes whole-flower cannabis, milled cannabis, cannabis oils, and vaporizers.
Currently Aurora has three operational facilities in Canada (Aurora Sky, Aurora Vie, and Aurora Mountain) plus two new facilities projected to be operational by the end of 2018, including a 1,000,000 square foot facility under construction in Odense, Denmark. The Company’s facilities include a 55,200-square-foot production facility in Mountain View County completed in 2015. Aurora Vie is a 40,000-square-foot, fully licensed, indoor production facility in Pointe-Claire, Quebec. It was the second licensed producer in Quebec, and was acquired in 2017 for $7 million. The Company is also currently constructing an automated 800,000-square-foot plant in Alberta that it said would be capable of producing 100,000 kilograms of cannabis annually. The land is part of the acreage owned by the Edmonton International Airport.
Aurora Cannabis was founded by Terry Booth, Steve Dobler, Dale Lesak and Chris Mayerson in 2013. Using much of their own money the group initially secured a 160+ acre parcel of land in Mountain View County, Alberta. The company received its license to grow cannabis as well as its licence to sell medical cannabis both in 2014.
To Find out the inside Scoop on Aurora Cannabis Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
Aurora also holds stakes in a leading extraction technology company, Radient Technologies Inc., based in Edmonton, and is in the process of completing an investment in Edmonton-based Hempco Food and Fiber Inc. Aurora is the cornerstone investor in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis. Aurora also owns Pedanios, a leading wholesale importer, exporter, and distributor of medical cannabis in the European Union based in Germany.
Aurora’s growth has been fueled by acquisitions and currently the Company’s subsidiaries include Pedanios Gmbh, Germany’s largest distributor of cannabis to pharmacies, CanvasRx, the largest medical cannabis patient outreach service in Canada, BC Northern Lights, an indoor growing supplies manufacturer, Aurora-Larssen Projects, a globally leading greenhouse engineering and design consultancy, and H2 Biopharma, a late-stage ACMPR applicant in Quebec.
On November 5 Aurora announced the official opening of its latest elite, high-tech cannabis production facility in Lachute, Quebec, known to the world as Aurora “Eau.” At 48,000 square feet, with 11 purpose-built grow rooms, Aurora Eau will produce up to 4,500 kg of high quality cannabis per year, all in a facility with some of the lowest electricity costs in North America. It is designed to grow niche varieties of cannabis for the premium medical and adult consumer use markets in Quebec, Canada and around the world. Eau becomes Aurora’s second production facility in Quebec, the first being Aurora Vie, a 40,000 square foot indoor grow facility in Pointe Claire, Quebec.
Designed and built to meet strict European Union GMP standards and built mainly by local contractors, Aurora Eau is expected to create more than 100 full-time jobs for local area residents. For future development, it has additional manufacturing suites, which allow for increased value-add production. Throughout the construction phase of the project, Aurora injected more than $12 million into the regional community and will continue to support its economic development in coming years, playing a key role in growing the local economy. The facility is strategically located on 46 acres of land, which allows for significant future expansion potential.
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $7 billion market valuation Aurora has $89 million in the treasury and massive revenues reporting $55.2 million in revenues for the year ended June 30, 2018 up from $18 million last year. Led by Terry Booth, the youngest master electrician on record in Alberta (at 22) Aurora, which is about to up-list to the NYSE is one of the world’s largest and leading cannabis companies with funded capacity in excess of 570,000 kg per year at its nine grow operations in Canada and Denmark. The recent move to the NYSE gives Aurora increased exposure to a vast array of US institutional and retail investors. We will be updating on Aurora when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with Aurora.
Sign Up now for our 100% FREE Penny Stock Newsletter
Disclosure: we hold no position in Aurora either long or short and we have not been compensated for this report.